Literature DB >> 19836942

Stem cells and spinal cord regeneration.

Sharyn L Rossi1, Hans S Keirstead.   

Abstract

Cell-based transplantation strategies are inherently combination therapies, as they may mediate spinal cord repair via trophic or phenotypic mechanisms. The growth factor expression profile and phenotype of transplanted cells are determined by the transplant population as well as by the site into which they are transplanted. Identifying the key pathways involved in transplant survival and differentiation, as well as neuroprotection and regeneration of endogenous tissue, will enable manipulation of both the transplanted cells and the microenvironment to improve transplant efficiency. High purity populations derived from stem cells will serve to better delineate lineage-specific mechanisms of repair, while providing both neurotrophic and phenotypic benefits to the injured spinal cord.

Mesh:

Year:  2009        PMID: 19836942     DOI: 10.1016/j.copbio.2009.09.008

Source DB:  PubMed          Journal:  Curr Opin Biotechnol        ISSN: 0958-1669            Impact factor:   9.740


  16 in total

Review 1.  Progress and prospects in neurorehabilitation: clinical applications of stem cells and brain-computer interface for spinal cord lesions.

Authors:  Mariana Gongora; Caroline Peressutti; Sergio Machado; Silmar Teixeira; Bruna Velasques; Pedro Ribeiro
Journal:  Neurol Sci       Date:  2012-11-17       Impact factor: 3.307

2.  An in vivo characterization of trophic factor production following neural precursor cell or bone marrow stromal cell transplantation for spinal cord injury.

Authors:  Gregory W J Hawryluk; Andrea Mothe; Jian Wang; Shelly Wang; Charles Tator; Michael G Fehlings
Journal:  Stem Cells Dev       Date:  2012-02-07       Impact factor: 3.272

3.  Neurotrophins: potential therapeutic tools for the treatment of spinal cord injury.

Authors:  Edmund R Hollis; Mark H Tuszynski
Journal:  Neurotherapeutics       Date:  2011-10       Impact factor: 7.620

Review 4.  Injured mice at the gym: review, results and considerations for combining chondroitinase and locomotor exercise to enhance recovery after spinal cord injury.

Authors:  Lyn B Jakeman; Emily L Hoschouer; D Michele Basso
Journal:  Brain Res Bull       Date:  2010-06-15       Impact factor: 4.077

5.  Quantitative temporal proteomic analysis of human embryonic stem cell differentiation into oligodendrocyte progenitor cells.

Authors:  Raghothama Chaerkady; Brian Letzen; Santosh Renuse; Nandini A Sahasrabuddhe; Praveen Kumar; Angelo H All; Nitish V Thakor; Bernard Delanghe; John D Gearhart; Akhilesh Pandey; Candace L Kerr
Journal:  Proteomics       Date:  2011-09-02       Impact factor: 3.984

Review 6.  Neural stem cells and strategies for the regeneration of the central nervous system.

Authors:  Hideyuki Okano
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2010       Impact factor: 3.493

7.  Effects of combinatorial treatment with pituitary adenylate cyclase activating peptide and human mesenchymal stem cells on spinal cord tissue repair.

Authors:  Kuan-Min Fang; Jen-Kun Chen; Shih-Chieh Hung; Mei-Chun Chen; Yi-Ting Wu; Tsung-Jung Wu; Hsin-I Lin; Chia-Hua Chen; Henrich Cheng; Chung-Shi Yang; Shun-Fen Tzeng
Journal:  PLoS One       Date:  2010-12-20       Impact factor: 3.240

8.  Grafted human embryonic progenitors expressing neurogenin-2 stimulate axonal sprouting and improve motor recovery after severe spinal cord injury.

Authors:  Florence E Perrin; Guillaume Boniface; Che Serguera; Nicolas Lonjon; Angeline Serre; Monica Prieto; Jacques Mallet; Alain Privat
Journal:  PLoS One       Date:  2010-12-30       Impact factor: 3.240

Review 9.  What is the potential of oligodendrocyte progenitor cells to successfully treat human spinal cord injury?

Authors:  Robert A Watson; Trevor M Yeung
Journal:  BMC Neurol       Date:  2011-09-23       Impact factor: 2.474

10.  Effect of BDNF and Other Potential Survival Factors in Models of In Vitro Oxidative Stress on Adult Spinal Cord-Derived Neural Stem/Progenitor Cells.

Authors:  Laureen D Hachem; Andrea J Mothe; Charles H Tator
Journal:  Biores Open Access       Date:  2015-02-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.